Edesa Biotech, Inc. (EDSA) stock
EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.17+0.11 (+5.58%)
Close on Nov 19, 2026Market cap $20.97MP/E –Yield –
Edesa Biotech pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Edesa Biotech
Edesa Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?